Opko Health (OPK) Research & Development (2016 - 2025)
Historic Research & Development for Opko Health (OPK) over the last 16 years, with Q3 2025 value amounting to $30.1 million.
- Opko Health's Research & Development rose 454.64% to $30.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $121.7 million, marking a year-over-year increase of 2920.17%. This contributed to the annual value of $105.2 million for FY2024, which is 1743.55% up from last year.
- Latest data reveals that Opko Health reported Research & Development of $30.1 million as of Q3 2025, which was up 454.64% from $30.3 million recorded in Q2 2025.
- Opko Health's 5-year Research & Development high stood at $32.6 million for Q1 2023, and its period low was $17.3 million during Q2 2022.
- Its 5-year average for Research & Development is $23.0 million, with a median of $19.5 million in 2022.
- Per our database at Business Quant, Opko Health's Research & Development skyrocketed by 7805.26% in 2023 and then crashed by 3271.89% in 2024.
- Opko Health's Research & Development (Quarter) stood at $21.0 million in 2021, then fell by 7.04% to $19.5 million in 2022, then fell by 0.69% to $19.4 million in 2023, then skyrocketed by 56.88% to $30.4 million in 2024, then fell by 1.14% to $30.1 million in 2025.
- Its Research & Development was $30.1 million in Q3 2025, compared to $30.3 million in Q2 2025 and $30.8 million in Q1 2025.